Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003546567 | SCV004270592 | uncertain significance | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 164 of the C1QC protein (p.Gly164Ser). This variant is present in population databases (rs752596663, gnomAD 0.004%). This missense change has been observed in individual(s) with C1QC-related conditions (PMID: 24157463). ClinVar contains an entry for this variant (Variation ID: 440743). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV003221355 | SCV000606735 | pathogenic | C1Q deficiency 3 | 2023-07-31 | no assertion criteria provided | literature only | |
Biochemical Molecular Genetic Laboratory, |
RCV000508986 | SCV001132833 | pathogenic | C1Q deficiency | 2019-01-29 | no assertion criteria provided | clinical testing |